Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections

Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections

US Patent 7943118 · Granted May 17, 2011

Estimated economic value: $148,620,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating neurodegenerative disease with substituted n-hexanoic-l-tyro2025
Methods and compositions of isoindoline-1,3-dione and isoindole prodrugs useful 2023
Systems and methods for routing messages through wireless networks2021
Compounds2021
Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial2015
Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial2015
Bi-functional pyrazolopyridine compounds2013
Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial2013
Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial2013
Bi-functional quinoline analogs2013
Bi-functional pyrazolopyridine compounds2013
Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial2013